Journal of the American Medical Association (JAMA) Publishes Results from First-Ever Randomized, Placebo-Controlled Clinical Trial Assessing the Dose-Dependent Efficacy of MM120 (Lysergide D-Tartrate, LSD) in Generalized Anxiety Disorder (GAD) – Business Wire

Written by

admin

in

  1. Journal of the American Medical Association (JAMA) Publishes Results from First-Ever Randomized, Placebo-Controlled Clinical Trial Assessing the Dose-Dependent Efficacy of MM120 (Lysergide D-Tartrate, LSD) in Generalized Anxiety Disorder (GAD)  Business Wire
  2. A single dose of LSD seems to reduce anxiety  New Scientist
  3. Researchers pinpoint LSD dose that could keep anxiety at bay for weeks  Yahoo News Canada
  4. LSD shows promise for reducing anxiety in drugmaker’s midstage study  The Independent

Continue Reading

More posts